NMS·Healthcare·$2.0B·#144 / 520 in Healthcare
OMCL Omnicell, Inc.
59SPECULATIVE
CATEGORY BREAKDOWN
GROWTH10
QUALITY47
STABILITY96
VALUATION97
GOVERNANCE45
METRIC BREAKDOWN
Revenue Growth (YoY)
Year-over-year revenue growth rate
+6.5%
10
> 50% strong
Gross Margin
Revenue retained after direct costs
42.5%
59
> 50% strong
Cash Runway
Months of cash at current burn rate
999 months
100
> 24 months ideal
Debt / Equity
Total debt relative to shareholder equity
16.6%
87
< 25% strong
Price / Sales
Market cap relative to trailing revenue
1.6x
97
< 3x strong
Rule of 40
Growth rate plus operating margin
7
30
> 40 excellent
Insider Ownership
Percentage of shares held by insiders
2.2%
18
> 20% strong
Share Dilution (12M)
Share count increase over last 12 months
-20.4%
100
< 5% ideal
SCORE HISTORY
RELATED STOCKS
COMPARE OMCL WITH…
OR QUICK-COMPARE SECTOR PEERS
SCORE ALERT
Get notified when OMCL's score changes by 5+ points.
DATA INFO
Last updated: May 4, 2026
Sources: SEC EDGAR, Financial Modeling Prep, Yahoo Finance. Not financial advice.